Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds Free

Abstract

Several disulfide-based and azoic compounds have shown antiviral and virucidal properties against arenaviruses in virus yield-inhibition and inactivation assays, respectively. The most effective virucidal agent, the aromatic disulfide NSC20625, was able to inactivate two strains of the prototype arenavirus species (LCMV). Inactivated viral particles retained the biological functions of the virion envelope glycoproteins in virus binding and uptake, but were unable to perform viral RNA replication. Furthermore, in inactivated virions, the electrophoretic profile of the Z protein was altered when analysed under non-reducing conditions, whereas the patterns of the proteins NP and GP1 remained unaffected. Treatment of a recombinant LCMV Z protein with the virucidal agents induced unfolding and oligomerization of Z to high-molecular-mass aggregates, probably due to metal-ion ejection and the formation of intermolecular disulfide bonds through the cysteine residues of the Z RING finger. NSC20625 also exhibited antiviral properties in LCMV-infected cells without affecting other cellular RING-motif proteins, such as the promyelocytic leukaemia protein PML. Altogether, the investigations described here illustrate the potential of the Z protein as a promising target for therapy and the prospects of the Z-reactive compounds to prevent arenavirus dissemination.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81667-0
2006-05-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/5/1217.html?itemId=/content/journal/jgv/10.1099/vir.0.81667-0&mimeType=html&fmt=ahah

References

  1. Albiol Matanic V. C., Castilla V. 2004; Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int J Antimicrob Agents 23:382–389 [CrossRef]
    [Google Scholar]
  2. Andrei G., De Clercq E. 1990; Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res 14:287–299 [CrossRef]
    [Google Scholar]
  3. Auperin D. D., Romanowski V., Galinski M., Bishop D. H. L. 1984; Sequencing studies of Pichinde arenavirus S RNA indicate a novel coding strategy, an ambisense viral S RNA. J Virol 52:897–904
    [Google Scholar]
  4. Bartolotta S., García C. C., Candurra N. A., Damonte E. B. 2001; Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol 146:777–790 [CrossRef]
    [Google Scholar]
  5. Borden K. L. B., Boddy M. N., Lally J., O'Reilly N. J., Martin S., Howe K., Solomon E., Freemont P. S. 1995; The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14:1532–1541
    [Google Scholar]
  6. Borden K. L. B., Campbell Dwyer E. J., Carlile G. W., Djavani M., Salvato M. S. 1998a; Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72:3819–3826
    [Google Scholar]
  7. Borden K. L. B., Campbell Dwyer E. J., Salvato M. S. 1998b; An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758–766
    [Google Scholar]
  8. Brzovic P. S., Meza J., King M.-C., Klevit R. E. 1998; The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain. J Biol Chem 273:7795–7799 [CrossRef]
    [Google Scholar]
  9. Burns N. J. III, Barnett B. B., Huffman J. H., Dawson M. I., Sidwell R. W., De Clercq E., Kende M. 1988; A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. Antiviral Res 10:89–98 [CrossRef]
    [Google Scholar]
  10. Campbell Dwyer E. J., Lai H., MacDonald R. C., Salvato M. S., Borden K. L. B. 2000; The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J Virol 74:3293–3300 [CrossRef]
    [Google Scholar]
  11. Candurra N. A., Maskin L., Damonte E. B. 1996; Inhibition of arenavirus multiplication in vitro by phenotiazines. Antiviral Res 31:149–158 [CrossRef]
    [Google Scholar]
  12. Capili A. D., Schultz D. C., Rauscher F. J. III, Borden K. L. B. 2001; Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J 20:165–177 [CrossRef]
    [Google Scholar]
  13. Castilla V., Barquero A. A., Mersich S. E., Coto C. E. 1998; In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves. Int J Antimicrob Agents 10:67–75 [CrossRef]
    [Google Scholar]
  14. Charrel R. N., Lemasson J.-J., Garbutt M., Khelifa R., De Micco P., Feldmann H., de Lamballerie X. 2003; New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. Virology 317:191–196 [CrossRef]
    [Google Scholar]
  15. Chen X., Chu M., Giedroc D. P. 2000; Spectroscopic characterization of Co(II)-, Ni(II)-, and Cd(II)-substituted wild-type and non-native retroviral-type zinc finger peptides. J Biol Inorg Chem 5:93–101
    [Google Scholar]
  16. Clegg J. C. S. 2002; Molecular phylogeny of the arenaviruses. Curr Top Microbiol Immunol 262:1–24
    [Google Scholar]
  17. Cordo S. M., Candurra N. A., Damonte E. B. 1999; Myristic acid analogs are inhibitors of Junin virus replication. Microbes Infect 1:609–614 [CrossRef]
    [Google Scholar]
  18. Cornu T. I., de la Torre J. C. 2001; RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J Virol 75:9415–9426 [CrossRef]
    [Google Scholar]
  19. Cornu T. I., de la Torre J. C. 2002; Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis. J Virol 76:6678–6688 [CrossRef]
    [Google Scholar]
  20. Damonte E. B., Coto C. E. 2002; Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv Virus Res 58:125–155
    [Google Scholar]
  21. Damonte E. B., Mersich S. E., Candurra N. A. 1994; Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity. Virus Res 34:317–326 [CrossRef]
    [Google Scholar]
  22. Djavani M., Topisirovic I., Zapata J. C. & 8 other authors 2005; The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J Virol 79:2461–2473 [CrossRef]
    [Google Scholar]
  23. Eichler R., Lenz O., Strecker T., Eickmann M., Klenk H.-D., Garten W. 2003a; Identification of Lassa virus glycoprotein signal peptide as a trans -acting maturation factor. EMBO Rep 4:1084–1088 [CrossRef]
    [Google Scholar]
  24. Eichler R., Lenz O., Strecker T., Garten W. 2003b; Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 538:203–206 [CrossRef]
    [Google Scholar]
  25. Eichler R., Strecker T., Kolesnikova L., ter Meulen J., Weissenhorn W., Becker S., Klenk H. D., Garten W., Lenz O. 2004; Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP. Virus Res 100:249–255 [CrossRef]
    [Google Scholar]
  26. Enría D. A., Maiztegui J. I. 1994; Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res 23:23–31 [CrossRef]
    [Google Scholar]
  27. Fasman G. D. (editor) 1996 Circular Dichroism and the Conformational Analysis of Biomolecules New York: Plenum;
    [Google Scholar]
  28. Franze-Fernández M. T., Iapalucci S., López N., Rossi C. 1993; Subgenomic RNAs of Tacaribe virus. In The Arenaviridae pp  113–132 Edited by Salvato M. S. New York: Plenum;
    [Google Scholar]
  29. Freed E. O. 2002; Viral late domains. J Virol 76:4679–4687 [CrossRef]
    [Google Scholar]
  30. García C. C., Candurra N. A., Damonte E. B. 2000; Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antivir Chem Chemother 11:231–238 [CrossRef]
    [Google Scholar]
  31. García C. C., Candurra N. A., Damonte E. B. 2002a; Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res 55:437–446 [CrossRef]
    [Google Scholar]
  32. García C. C., Rosso M. L., Bertoni M. D., Maier M. S., Damonte E. B. 2002b; Evaluation of the antiviral activity against Junin virus of macrocyclic trichothecenes produced by the hypocrealean epibiont of Baccharis coridifolia . Planta Med 68:209–212 [CrossRef]
    [Google Scholar]
  33. García C. C., Brousse B. N., Carlucci M. J., Moglioni A. G., Martins Alho M., Moltrasio G. Y., D'Accorso N. B., Damonte E. B. 2003a; Inhibitory effect of thiosemicarbazone derivatives on Junin virus replication in vitro. Antivir Chem Chemother 14:99–105 [CrossRef]
    [Google Scholar]
  34. García C. C., Candurra N. A., Damonte E. B. 2003b; Differential inhibitory action of two azoic compounds against arenaviruses. Int J Antimicrob Agents 21:319–324 [CrossRef]
    [Google Scholar]
  35. Garcin D., Rochat S., Kolakofsky D. 1993; The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J Virol 67:807–812
    [Google Scholar]
  36. Grande-Pérez A., Lázaro E., Lowenstein P., Domingo E., Manrubia S. C. 2005; Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102:4448–4452 [CrossRef]
    [Google Scholar]
  37. Guillerm G., Guillerm D., Vandenplas-Vitkowski C., Glapski C., De Clercq E. 2003; Inactivation of S -adenosyl-l-homocysteine hydrolase with novel 5′-thioadenosine derivatives. Antiviral effects. Bioorg Med Chem Lett 13:1649–1652 [CrossRef]
    [Google Scholar]
  38. Hass M., Gölnitz U., Müller S., Becker-Ziaja B., Günther S. 2004; Replicon system for Lassa virus. J Virol 78:13793–13803 [CrossRef]
    [Google Scholar]
  39. Howard C. R. 1993; Antigenic diversity among the arenaviruses. In The Arenaviridae pp  37–49 Edited by Salvato M. S. New York: Plenum;
    [Google Scholar]
  40. Huang M., Maynard A., Turpin J. A., Graham L., Janini G. M., Covell D. G., Rice W. G. 1998; Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins. J Med Chem 41:1371–1381 [CrossRef]
    [Google Scholar]
  41. Huggins J. W., Robins R. K., Canonico P. G. 1984; Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob Agents Chemother 26:476–480 [CrossRef]
    [Google Scholar]
  42. Kentsis A., Gordon R. E., Borden K. L. B. 2002; Self-assembly properties of a model RING domain. Proc Natl Acad Sci U S A 99:667–672 [CrossRef]
    [Google Scholar]
  43. López N., Jácamo R., Franze-Fernández M. T. 2001; Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75:12241–12251 [CrossRef]
    [Google Scholar]
  44. McCormick J. B., Fisher-Hoch S. P. 2002; Lassa fever. Curr Top Microbiol Immunol 262:75–109
    [Google Scholar]
  45. McCormick J. B., King I. J., Webb P. A., Scribner C. L., Craven R. B., Johnson K. M., Elliot L. H., Belmont-Williams R. 1986; Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20–26 [CrossRef]
    [Google Scholar]
  46. McKee K. T. Jr, Huggins J. W., Trahan C. J., Mahlandi B. G. 1988; Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever. Antimicrob Agents Chemother 32:1304–1309 [CrossRef]
    [Google Scholar]
  47. Miller Jenkins L. M., Byrd J. C., Hara T. & 7 other authors 2005; Studies on the mechanism of inactivation of the HIV-1 nucleocapsid protein NCp7 with 2-mercaptobenzamide thioesters. J Med Chem 48:2847–2858 [CrossRef]
    [Google Scholar]
  48. Neuman B. W., Adair B. D., Burns J. W., Milligan R. A., Buchmeier M. J., Yeager M. 2005; Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J Virol 79:3822–3830 [CrossRef]
    [Google Scholar]
  49. Perez M., Craven R. C., de la Torre J. C. 2003; The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100:12978–12983 [CrossRef]
    [Google Scholar]
  50. Perez M., Greenwald D. L., de la Torre J. C. 2004; Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol 78:11443–11448 [CrossRef]
    [Google Scholar]
  51. Peters C. J. 2002; Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol 262:65–74
    [Google Scholar]
  52. Rein A., Ott D. E., Mirro J., Arthur L. O., Rice W., Henderson L. E. 1996; Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein. J Virol 70:4966–4972
    [Google Scholar]
  53. Rice W. G., Turpin J. A., Schaeffer C. A. & 7 other authors 1996; Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J Med Chem 39:3606–3616 [CrossRef]
    [Google Scholar]
  54. Roehm P. C., Berg J. M. 1997; Sequential metal binding by the RING finger domain of BRCA1. Biochemistry 36:10240–10245 [CrossRef]
    [Google Scholar]
  55. Rotz L. D., Khan A. S., Lillibridge S. R., Ostroff S. M., Hughes J. M. 2002; Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8:225–230 [CrossRef]
    [Google Scholar]
  56. Salvato M. S. 1993; Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus. In The Arenaviridae pp  133–156 Edited by Salvato M. S. New York: Plenum;
    [Google Scholar]
  57. Salvato M. S., Shimomaye E. M. 1989; The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 173:1–10 [CrossRef]
    [Google Scholar]
  58. Salvato M. S., Schweighofer K. J., Burns J., Shimomaye E. M. 1992; Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res 22:185–198 [CrossRef]
    [Google Scholar]
  59. Salvato M. S., Clegg J. C. S., Buchmeier M. J., Charrel R. N., Gonzalez J.-P., Lukashevich I. S., Peters C. J., Rico-Hesse R., Romanowski V. 2005; Arenaviridae . In Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses pp  725–733 Edited by Fauquet C. M., Mayo M. A., Maniloff J., Desselberger U., Ball L. A. London: Elsevier/Academic Press;
    [Google Scholar]
  60. Sánchez A. B., Perez M., Cornu T., de la Torre J. C. 2005; RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 79:11071–11081 [CrossRef]
    [Google Scholar]
  61. Smee D. F., Morris J. L., Barnard D. L., Van Aerschot A. 1992; Selective inhibition of arthropod-borne and arenaviruses in vitro by 3′-fluoro-3′-deoxyadenosine. Antiviral Res 18:151–162 [CrossRef]
    [Google Scholar]
  62. Smee D. F., Gilbert J., Leonhardt J. A., Barnett B. B., Huggins J. H., Sidwell R. W. 1993; Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. Antiviral Res 20:57–70
    [Google Scholar]
  63. Strecker T., Eichler R., ter Meulen J., Weissenhorn W., Klenk H. D., Garten W., Lenz O. 2003; Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles. J Virol 77:10700–10705 [CrossRef]
    [Google Scholar]
  64. Topisirovic I., Capili A. D., Borden K. L. B. 2002; Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner. Mol Cell Biol 22:6183–6198 [CrossRef]
    [Google Scholar]
  65. Tortorici M. A., Ghiringhelli P. D., Lozano M. E., Albariño C. G., Romanowski V. 2001; Zinc-binding properties of Junín virus nucleocapsid protein. J Gen Virol 82:121–128
    [Google Scholar]
  66. Tummino P. J., Harvey P. J., McQuade T., Domagala J., Gogliotti R., Sanchez J., Song Y., Hupe D. 1997; The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Antimicrob Agents Chemother 41:394–400
    [Google Scholar]
  67. Turpin J. A., Song Y., Inman J. K., Huang M., Wallqvist A., Maynard A., Covell D. G., Rice W. G., Appella E. 1999; Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J Med Chem 42:67–86 [CrossRef]
    [Google Scholar]
  68. Uckun F. M., Petkevich A. S., Vassilev A. O., Tibbles H. E., Titov L. 2004; Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by Lassa virus. BMC Infect Dis 4:1 [CrossRef]
    [Google Scholar]
  69. Wachsman M. B., López E. M. F., Ramírez J. A., Galagovsky L. R., Coto C. E. 2000; Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antivir Chem Chemother 11:71–77 [CrossRef]
    [Google Scholar]
  70. Witvrouw M., Desmyter J., De Clercq E. 1994; Antiviral portrait series. 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antivir Chem Chemother 5:345–359 [CrossRef]
    [Google Scholar]
  71. Wulff H., Lange J. V., Webb P. A. 1978; Interrelationships among arenaviruses measured by indirect immunofluorescence. Intervirology 9:344–350 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81667-0
Loading
/content/journal/jgv/10.1099/vir.0.81667-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed